• Nenhum resultado encontrado

Analysis of the correlation between p53 and bcl-2 expression with staging and prognosis of the colorectal adenocarcinoma

N/A
N/A
Protected

Academic year: 2017

Share "Analysis of the correlation between p53 and bcl-2 expression with staging and prognosis of the colorectal adenocarcinoma"

Copied!
5
0
0

Texto

Loading

Imagem

TABLE 1 - Colorectal adenocarcinoma patients characteristics.
TABLE 2 - Tumour expression of p53, bcl-2 and associated p53/bcl-2. p53 bcl-2 p53 and bcl-2 n (%) n.(%) n.(%) positive 14(11) 58(50) 11(14,6) negative 104(89) 58(50) 64(85,4) Total 108(100) 116(100) 75(100)
TABLE 5 - bcl-2 tumour expression and TNM staging.

Referências

Documentos relacionados

The present study analyzed the immunohistochemical expressions of MMP-1, MMP-7 and VEGF in colorectal adenocarcinoma cases and determined the correlations between this group of

PURPOSE : To evaluate the immunohistochemical expression of p16, Ki-67, p53 and Bcl-2 proteins in gastrointestinal stromal tumors (GIST); to assess the possible association

Comparative study between the free DNA in peripheral blood and TNM staging in patients with colorectal cancer for prognostic evaluation in the university hospital of the State

Increased expression of VEGF, p53, Rb and Bcl-2 can affect resistance to chemotherapy.(57) Expression of VEGF is a prognostic indicator in patients with lung cancer, participating

The structure of the remelting zone of the steel C90 steel be- fore conventional tempering consitute cells, dendritic cells, sur- rounded with the cementite, inside of

The correlation between TNM classification and histological scores of malignancy, and the correlation of these parameters with the prognosis was evaluated in 16 cases of squamous

Apoptosis in colorectal carcinoma occurring in patients aged 45 years and under: relantionship to prognosis, mitosis and immunohistochemical demonstration of p53, c-myc and

Objectives - To evaluated p53, cyclin D1 and Bcl-2 immunoexpressions in esophagogastric junction adenocarcinoma patients, without Barrett’s esophagus, and to compared